• レポートコード:MRC308GR11488 • 出版社/出版日:GlobalInfoResearch / 2023年8月 • レポート形態:英文、PDF、114ページ • 納品方法:Eメール(2-3営業日) • 産業分類:医薬品&ヘルスケア |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Corporate User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界の非オピオイド局所鎮痛剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の非オピオイド局所鎮痛剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 非オピオイド局所鎮痛剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
非オピオイド局所鎮痛剤市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・処方鎮痛剤、市販鎮痛剤
用途別セグメント
・薬局、クリニック、病院、その他
主要な市場プレーヤー
・Johnson and Johnson、GlaxoSmithKline、Pfizer、Hisamitsu、Mylan、Reckitt Benckiser Group、Sanofi、Teva Pharmaceutical、Sun Pharmaceutical Industries、Lingrui Pharmaceutical、Tibet Cheezheng Tibetan Medicine、China Resources Sanjiu Medical & Pharmaceutical、Topical BioMedics、AdvaCare Pharma、Abacus Health Products
地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)
本調査レポートの内容は計15章あります。
・第1章では、非オピオイド局所鎮痛剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非オピオイド局所鎮痛剤メーカーの企業概要、2019年~2022年までの非オピオイド局所鎮痛剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非オピオイド局所鎮痛剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別非オピオイド局所鎮痛剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの非オピオイド局所鎮痛剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での非オピオイド局所鎮痛剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および非オピオイド局所鎮痛剤の産業チェーンを掲載しています。
・第14、15章では、非オピオイド局所鎮痛剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 非オピオイド局所鎮痛剤の概要
– 種類別分析(2018年vs2022年vs2029年):処方鎮痛剤、市販鎮痛剤
– 用途別分析(2018年vs2022年vs2029年):薬局、クリニック、病院、その他
– 世界の非オピオイド局所鎮痛剤市場規模・予測
– 世界の非オピオイド局所鎮痛剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Johnson and Johnson、GlaxoSmithKline、Pfizer、Hisamitsu、Mylan、Reckitt Benckiser Group、Sanofi、Teva Pharmaceutical、Sun Pharmaceutical Industries、Lingrui Pharmaceutical、Tibet Cheezheng Tibetan Medicine、China Resources Sanjiu Medical & Pharmaceutical、Topical BioMedics、AdvaCare Pharma、Abacus Health Products
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:処方鎮痛剤、市販鎮痛剤
・用途別分析2018年-2029年:薬局、クリニック、病院、その他
・非オピオイド局所鎮痛剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・非オピオイド局所鎮痛剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・非オピオイド局所鎮痛剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・非オピオイド局所鎮痛剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・非オピオイド局所鎮痛剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Non-opioid Topical Pain Relief
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-opioid Topical Pain Relief Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prescription Pain Relief
1.3.3 Over-The-Counter Pain Relief
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-opioid Topical Pain Relief Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmacy
1.4.3 Clinic
1.4.4 Hospital
1.4.5 Others
1.5 Global Non-opioid Topical Pain Relief Market Size & Forecast
1.5.1 Global Non-opioid Topical Pain Relief Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-opioid Topical Pain Relief Sales Quantity (2018-2029)
1.5.3 Global Non-opioid Topical Pain Relief Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Johnson and Johnson
2.1.1 Johnson and Johnson Details
2.1.2 Johnson and Johnson Major Business
2.1.3 Johnson and Johnson Non-opioid Topical Pain Relief Product and Services
2.1.4 Johnson and Johnson Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson and Johnson Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Non-opioid Topical Pain Relief Product and Services
2.2.4 GlaxoSmithKline Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Non-opioid Topical Pain Relief Product and Services
2.3.4 Pfizer Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Hisamitsu
2.4.1 Hisamitsu Details
2.4.2 Hisamitsu Major Business
2.4.3 Hisamitsu Non-opioid Topical Pain Relief Product and Services
2.4.4 Hisamitsu Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hisamitsu Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Non-opioid Topical Pain Relief Product and Services
2.5.4 Mylan Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mylan Recent Developments/Updates
2.6 Reckitt Benckiser Group
2.6.1 Reckitt Benckiser Group Details
2.6.2 Reckitt Benckiser Group Major Business
2.6.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product and Services
2.6.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Reckitt Benckiser Group Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Non-opioid Topical Pain Relief Product and Services
2.7.4 Sanofi Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Product and Services
2.8.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical Recent Developments/Updates
2.9 Sun Pharmaceutical Industries
2.9.1 Sun Pharmaceutical Industries Details
2.9.2 Sun Pharmaceutical Industries Major Business
2.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product and Services
2.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.10 Lingrui Pharmaceutical
2.10.1 Lingrui Pharmaceutical Details
2.10.2 Lingrui Pharmaceutical Major Business
2.10.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product and Services
2.10.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lingrui Pharmaceutical Recent Developments/Updates
2.11 Tibet Cheezheng Tibetan Medicine
2.11.1 Tibet Cheezheng Tibetan Medicine Details
2.11.2 Tibet Cheezheng Tibetan Medicine Major Business
2.11.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product and Services
2.11.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tibet Cheezheng Tibetan Medicine Recent Developments/Updates
2.12 China Resources Sanjiu Medical & Pharmaceutical
2.12.1 China Resources Sanjiu Medical & Pharmaceutical Details
2.12.2 China Resources Sanjiu Medical & Pharmaceutical Major Business
2.12.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product and Services
2.12.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments/Updates
2.13 Topical BioMedics
2.13.1 Topical BioMedics Details
2.13.2 Topical BioMedics Major Business
2.13.3 Topical BioMedics Non-opioid Topical Pain Relief Product and Services
2.13.4 Topical BioMedics Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Topical BioMedics Recent Developments/Updates
2.14 AdvaCare Pharma
2.14.1 AdvaCare Pharma Details
2.14.2 AdvaCare Pharma Major Business
2.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Product and Services
2.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 AdvaCare Pharma Recent Developments/Updates
2.15 Abacus Health Products
2.15.1 Abacus Health Products Details
2.15.2 Abacus Health Products Major Business
2.15.3 Abacus Health Products Non-opioid Topical Pain Relief Product and Services
2.15.4 Abacus Health Products Non-opioid Topical Pain Relief Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Abacus Health Products Recent Developments/Updates
3 Competitive Environment: Non-opioid Topical Pain Relief by Manufacturer
3.1 Global Non-opioid Topical Pain Relief Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-opioid Topical Pain Relief Revenue by Manufacturer (2018-2023)
3.3 Global Non-opioid Topical Pain Relief Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-opioid Topical Pain Relief by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-opioid Topical Pain Relief Manufacturer Market Share in 2022
3.4.2 Top 6 Non-opioid Topical Pain Relief Manufacturer Market Share in 2022
3.5 Non-opioid Topical Pain Relief Market: Overall Company Footprint Analysis
3.5.1 Non-opioid Topical Pain Relief Market: Region Footprint
3.5.2 Non-opioid Topical Pain Relief Market: Company Product Type Footprint
3.5.3 Non-opioid Topical Pain Relief Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-opioid Topical Pain Relief Market Size by Region
4.1.1 Global Non-opioid Topical Pain Relief Sales Quantity by Region (2018-2029)
4.1.2 Global Non-opioid Topical Pain Relief Consumption Value by Region (2018-2029)
4.1.3 Global Non-opioid Topical Pain Relief Average Price by Region (2018-2029)
4.2 North America Non-opioid Topical Pain Relief Consumption Value (2018-2029)
4.3 Europe Non-opioid Topical Pain Relief Consumption Value (2018-2029)
4.4 Asia-Pacific Non-opioid Topical Pain Relief Consumption Value (2018-2029)
4.5 South America Non-opioid Topical Pain Relief Consumption Value (2018-2029)
4.6 Middle East and Africa Non-opioid Topical Pain Relief Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2029)
5.2 Global Non-opioid Topical Pain Relief Consumption Value by Type (2018-2029)
5.3 Global Non-opioid Topical Pain Relief Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2029)
6.2 Global Non-opioid Topical Pain Relief Consumption Value by Application (2018-2029)
6.3 Global Non-opioid Topical Pain Relief Average Price by Application (2018-2029)
7 North America
7.1 North America Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2029)
7.2 North America Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2029)
7.3 North America Non-opioid Topical Pain Relief Market Size by Country
7.3.1 North America Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2029)
7.3.2 North America Non-opioid Topical Pain Relief Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2029)
8.2 Europe Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2029)
8.3 Europe Non-opioid Topical Pain Relief Market Size by Country
8.3.1 Europe Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-opioid Topical Pain Relief Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-opioid Topical Pain Relief Market Size by Region
9.3.1 Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-opioid Topical Pain Relief Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2029)
10.2 South America Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2029)
10.3 South America Non-opioid Topical Pain Relief Market Size by Country
10.3.1 South America Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2029)
10.3.2 South America Non-opioid Topical Pain Relief Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-opioid Topical Pain Relief Market Size by Country
11.3.1 Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-opioid Topical Pain Relief Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-opioid Topical Pain Relief Market Drivers
12.2 Non-opioid Topical Pain Relief Market Restraints
12.3 Non-opioid Topical Pain Relief Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-opioid Topical Pain Relief and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-opioid Topical Pain Relief
13.3 Non-opioid Topical Pain Relief Production Process
13.4 Non-opioid Topical Pain Relief Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-opioid Topical Pain Relief Typical Distributors
14.3 Non-opioid Topical Pain Relief Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Non-opioid Topical Pain Relief Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-opioid Topical Pain Relief Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson and Johnson Major Business
Table 5. Johnson and Johnson Non-opioid Topical Pain Relief Product and Services
Table 6. Johnson and Johnson Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Johnson and Johnson Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline Non-opioid Topical Pain Relief Product and Services
Table 11. GlaxoSmithKline Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Non-opioid Topical Pain Relief Product and Services
Table 16. Pfizer Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 19. Hisamitsu Major Business
Table 20. Hisamitsu Non-opioid Topical Pain Relief Product and Services
Table 21. Hisamitsu Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hisamitsu Recent Developments/Updates
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Non-opioid Topical Pain Relief Product and Services
Table 26. Mylan Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Mylan Recent Developments/Updates
Table 28. Reckitt Benckiser Group Basic Information, Manufacturing Base and Competitors
Table 29. Reckitt Benckiser Group Major Business
Table 30. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product and Services
Table 31. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Reckitt Benckiser Group Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Non-opioid Topical Pain Relief Product and Services
Table 36. Sanofi Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical Major Business
Table 40. Teva Pharmaceutical Non-opioid Topical Pain Relief Product and Services
Table 41. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical Recent Developments/Updates
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product and Services
Table 46. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun Pharmaceutical Industries Recent Developments/Updates
Table 48. Lingrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Lingrui Pharmaceutical Major Business
Table 50. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product and Services
Table 51. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Lingrui Pharmaceutical Recent Developments/Updates
Table 53. Tibet Cheezheng Tibetan Medicine Basic Information, Manufacturing Base and Competitors
Table 54. Tibet Cheezheng Tibetan Medicine Major Business
Table 55. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product and Services
Table 56. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tibet Cheezheng Tibetan Medicine Recent Developments/Updates
Table 58. China Resources Sanjiu Medical & Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. China Resources Sanjiu Medical & Pharmaceutical Major Business
Table 60. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product and Services
Table 61. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. China Resources Sanjiu Medical & Pharmaceutical Recent Developments/Updates
Table 63. Topical BioMedics Basic Information, Manufacturing Base and Competitors
Table 64. Topical BioMedics Major Business
Table 65. Topical BioMedics Non-opioid Topical Pain Relief Product and Services
Table 66. Topical BioMedics Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Topical BioMedics Recent Developments/Updates
Table 68. AdvaCare Pharma Basic Information, Manufacturing Base and Competitors
Table 69. AdvaCare Pharma Major Business
Table 70. AdvaCare Pharma Non-opioid Topical Pain Relief Product and Services
Table 71. AdvaCare Pharma Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. AdvaCare Pharma Recent Developments/Updates
Table 73. Abacus Health Products Basic Information, Manufacturing Base and Competitors
Table 74. Abacus Health Products Major Business
Table 75. Abacus Health Products Non-opioid Topical Pain Relief Product and Services
Table 76. Abacus Health Products Non-opioid Topical Pain Relief Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Abacus Health Products Recent Developments/Updates
Table 78. Global Non-opioid Topical Pain Relief Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Non-opioid Topical Pain Relief Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Non-opioid Topical Pain Relief Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Non-opioid Topical Pain Relief, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Non-opioid Topical Pain Relief Production Site of Key Manufacturer
Table 83. Non-opioid Topical Pain Relief Market: Company Product Type Footprint
Table 84. Non-opioid Topical Pain Relief Market: Company Product Application Footprint
Table 85. Non-opioid Topical Pain Relief New Market Entrants and Barriers to Market Entry
Table 86. Non-opioid Topical Pain Relief Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Non-opioid Topical Pain Relief Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Non-opioid Topical Pain Relief Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Non-opioid Topical Pain Relief Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Non-opioid Topical Pain Relief Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Non-opioid Topical Pain Relief Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Non-opioid Topical Pain Relief Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Non-opioid Topical Pain Relief Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Non-opioid Topical Pain Relief Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Non-opioid Topical Pain Relief Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Non-opioid Topical Pain Relief Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Non-opioid Topical Pain Relief Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Non-opioid Topical Pain Relief Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Non-opioid Topical Pain Relief Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Non-opioid Topical Pain Relief Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Non-opioid Topical Pain Relief Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Non-opioid Topical Pain Relief Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Non-opioid Topical Pain Relief Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Non-opioid Topical Pain Relief Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Non-opioid Topical Pain Relief Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Non-opioid Topical Pain Relief Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Non-opioid Topical Pain Relief Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Non-opioid Topical Pain Relief Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Non-opioid Topical Pain Relief Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Non-opioid Topical Pain Relief Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Non-opioid Topical Pain Relief Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Non-opioid Topical Pain Relief Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Non-opioid Topical Pain Relief Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Non-opioid Topical Pain Relief Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Non-opioid Topical Pain Relief Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Non-opioid Topical Pain Relief Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Non-opioid Topical Pain Relief Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Non-opioid Topical Pain Relief Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Non-opioid Topical Pain Relief Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Non-opioid Topical Pain Relief Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Non-opioid Topical Pain Relief Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Non-opioid Topical Pain Relief Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Non-opioid Topical Pain Relief Raw Material
Table 146. Key Manufacturers of Non-opioid Topical Pain Relief Raw Materials
Table 147. Non-opioid Topical Pain Relief Typical Distributors
Table 148. Non-opioid Topical Pain Relief Typical Customers
List of Figures
Figure 1. Non-opioid Topical Pain Relief Picture
Figure 2. Global Non-opioid Topical Pain Relief Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-opioid Topical Pain Relief Consumption Value Market Share by Type in 2022
Figure 4. Prescription Pain Relief Examples
Figure 5. Over-The-Counter Pain Relief Examples
Figure 6. Global Non-opioid Topical Pain Relief Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Non-opioid Topical Pain Relief Consumption Value Market Share by Application in 2022
Figure 8. Pharmacy Examples
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global Non-opioid Topical Pain Relief Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Non-opioid Topical Pain Relief Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Non-opioid Topical Pain Relief Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Non-opioid Topical Pain Relief Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Non-opioid Topical Pain Relief Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Non-opioid Topical Pain Relief Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Non-opioid Topical Pain Relief by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-opioid Topical Pain Relief Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Non-opioid Topical Pain Relief Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Non-opioid Topical Pain Relief Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Non-opioid Topical Pain Relief Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Non-opioid Topical Pain Relief Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Non-opioid Topical Pain Relief Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Non-opioid Topical Pain Relief Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Non-opioid Topical Pain Relief Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Non-opioid Topical Pain Relief Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Non-opioid Topical Pain Relief Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Non-opioid Topical Pain Relief Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Non-opioid Topical Pain Relief Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Non-opioid Topical Pain Relief Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Non-opioid Topical Pain Relief Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Non-opioid Topical Pain Relief Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Non-opioid Topical Pain Relief Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Non-opioid Topical Pain Relief Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Non-opioid Topical Pain Relief Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Non-opioid Topical Pain Relief Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Non-opioid Topical Pain Relief Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Non-opioid Topical Pain Relief Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Non-opioid Topical Pain Relief Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Non-opioid Topical Pain Relief Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Non-opioid Topical Pain Relief Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Non-opioid Topical Pain Relief Consumption Value Market Share by Region (2018-2029)
Figure 54. China Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Non-opioid Topical Pain Relief Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Non-opioid Topical Pain Relief Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Non-opioid Topical Pain Relief Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Non-opioid Topical Pain Relief Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Non-opioid Topical Pain Relief Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Non-opioid Topical Pain Relief Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Non-opioid Topical Pain Relief Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Non-opioid Topical Pain Relief Market Drivers
Figure 75. Non-opioid Topical Pain Relief Market Restraints
Figure 76. Non-opioid Topical Pain Relief Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-opioid Topical Pain Relief in 2022
Figure 79. Manufacturing Process Analysis of Non-opioid Topical Pain Relief
Figure 80. Non-opioid Topical Pain Relief Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source